DIFFERENCES IN THE LEVELS OF LIPID STATUS IN PATIENTS WITH ISACHEMIC HEART DISEASE AND MALIGNANT DISEASE

Arteriosclerosis is the basis of all cardiovascular diseases. Numerous risk factors lead to the rise of malignant and cardiovascular diseases. Those are: elevated artery blood pressure, raised plasma cholesterol and triglycerides, low level of HDL-cholesterol, smoking, diabetes mellitus, diet, lack...

Full description

Bibliographic Details
Main Authors: Beretka Atila, Branislava Brkic, Miodrag Djordjevic, Dragan Zecevic
Format: Article
Language:English
Published: University in Nis, Faculty of Medicine 2009-01-01
Series:Acta Medica Medianae
Subjects:
Online Access:http://publisher.medfak.ni.ac.rs/2009-html/1-broj/DIFFERENCES%20IN%20THE%20LEVELS....pdf
_version_ 1811267663234596864
author Beretka Atila
Branislava Brkic
Miodrag Djordjevic
Dragan Zecevic
author_facet Beretka Atila
Branislava Brkic
Miodrag Djordjevic
Dragan Zecevic
author_sort Beretka Atila
collection DOAJ
description Arteriosclerosis is the basis of all cardiovascular diseases. Numerous risk factors lead to the rise of malignant and cardiovascular diseases. Those are: elevated artery blood pressure, raised plasma cholesterol and triglycerides, low level of HDL-cholesterol, smoking, diabetes mellitus, diet, lack of physical exercises, heredity, stress, gender.The aim of the study was to compare the lipid status of patients with cardiovascular disease or malignancy.The database of the biochemical laboratory and oncology counseling unit of the "Ostrog Clinic" was used. The method of random sample was used and patients (n=29) of both genders were selected, who were at the age of 40 to 47, with cardiovascular diseases, and had significant occlusive coronary disease, which required operation or surgical revascularization procedure. The patients were classified in two groups: G1 (n=14) with statin therapy and G2 (n=15) without statin therapy. Both groups were statistically compared with a group of female patients (n=30) with breast cancer, who were between 37 and 69 years of age. Control group comprised 25 healthy subjects. Standard statistical methods were used for processing the lipid status parameters, namely: the arithmetic mean, standard deviation SDn and SDn-1, correlation coefficient, post hock test and a single factor analysis of variance.The results obtained have pointed to the existence of a marked hyperlipoproteinemia type 4 in the group of cardiovascular patients who did not use statin (G2). In G2, higher levels of cholesterol, LDL-cholesterol and plasma triglycerides in comparison with the control and G1, while the value of HDL-cholesterol was within the range of referent values. The obvious suppressing effect of statin on cholesterol and LDL-cholesterol was observed in G1. Group G3 had, in comparison with the control and cardiovascular patients, significantly lower levels of cholesterol and triglycerides in plasma, as well as lower index of atherosclerosis and lower risk factors for the development of atherosclerosis.Elevated levels of cholesterol, LDL-C and LDL/HDL-C are the important risk factors for atherosclerosis development. These lipids’ risk factors could be modified, especially in the primary prevention of cardiovascular diseases. Lower values of lipid parameters in patients with malignancy compared to patients with cardiovascular diseases indicated posibble lower risk for malignancy in these patients.
first_indexed 2024-04-12T21:06:47Z
format Article
id doaj.art-0763db41096e46aeb46b435769edebe4
institution Directory Open Access Journal
issn 0365-4478
language English
last_indexed 2024-04-12T21:06:47Z
publishDate 2009-01-01
publisher University in Nis, Faculty of Medicine
record_format Article
series Acta Medica Medianae
spelling doaj.art-0763db41096e46aeb46b435769edebe42022-12-22T03:16:41ZengUniversity in Nis, Faculty of MedicineActa Medica Medianae0365-44782009-01-014812023DIFFERENCES IN THE LEVELS OF LIPID STATUS IN PATIENTS WITH ISACHEMIC HEART DISEASE AND MALIGNANT DISEASEBeretka AtilaBranislava BrkicMiodrag DjordjevicDragan ZecevicArteriosclerosis is the basis of all cardiovascular diseases. Numerous risk factors lead to the rise of malignant and cardiovascular diseases. Those are: elevated artery blood pressure, raised plasma cholesterol and triglycerides, low level of HDL-cholesterol, smoking, diabetes mellitus, diet, lack of physical exercises, heredity, stress, gender.The aim of the study was to compare the lipid status of patients with cardiovascular disease or malignancy.The database of the biochemical laboratory and oncology counseling unit of the "Ostrog Clinic" was used. The method of random sample was used and patients (n=29) of both genders were selected, who were at the age of 40 to 47, with cardiovascular diseases, and had significant occlusive coronary disease, which required operation or surgical revascularization procedure. The patients were classified in two groups: G1 (n=14) with statin therapy and G2 (n=15) without statin therapy. Both groups were statistically compared with a group of female patients (n=30) with breast cancer, who were between 37 and 69 years of age. Control group comprised 25 healthy subjects. Standard statistical methods were used for processing the lipid status parameters, namely: the arithmetic mean, standard deviation SDn and SDn-1, correlation coefficient, post hock test and a single factor analysis of variance.The results obtained have pointed to the existence of a marked hyperlipoproteinemia type 4 in the group of cardiovascular patients who did not use statin (G2). In G2, higher levels of cholesterol, LDL-cholesterol and plasma triglycerides in comparison with the control and G1, while the value of HDL-cholesterol was within the range of referent values. The obvious suppressing effect of statin on cholesterol and LDL-cholesterol was observed in G1. Group G3 had, in comparison with the control and cardiovascular patients, significantly lower levels of cholesterol and triglycerides in plasma, as well as lower index of atherosclerosis and lower risk factors for the development of atherosclerosis.Elevated levels of cholesterol, LDL-C and LDL/HDL-C are the important risk factors for atherosclerosis development. These lipids’ risk factors could be modified, especially in the primary prevention of cardiovascular diseases. Lower values of lipid parameters in patients with malignancy compared to patients with cardiovascular diseases indicated posibble lower risk for malignancy in these patients.http://publisher.medfak.ni.ac.rs/2009-html/1-broj/DIFFERENCES%20IN%20THE%20LEVELS....pdflipid statuscardiovascular diseaserisk factorsmalignant disease
spellingShingle Beretka Atila
Branislava Brkic
Miodrag Djordjevic
Dragan Zecevic
DIFFERENCES IN THE LEVELS OF LIPID STATUS IN PATIENTS WITH ISACHEMIC HEART DISEASE AND MALIGNANT DISEASE
Acta Medica Medianae
lipid status
cardiovascular disease
risk factors
malignant disease
title DIFFERENCES IN THE LEVELS OF LIPID STATUS IN PATIENTS WITH ISACHEMIC HEART DISEASE AND MALIGNANT DISEASE
title_full DIFFERENCES IN THE LEVELS OF LIPID STATUS IN PATIENTS WITH ISACHEMIC HEART DISEASE AND MALIGNANT DISEASE
title_fullStr DIFFERENCES IN THE LEVELS OF LIPID STATUS IN PATIENTS WITH ISACHEMIC HEART DISEASE AND MALIGNANT DISEASE
title_full_unstemmed DIFFERENCES IN THE LEVELS OF LIPID STATUS IN PATIENTS WITH ISACHEMIC HEART DISEASE AND MALIGNANT DISEASE
title_short DIFFERENCES IN THE LEVELS OF LIPID STATUS IN PATIENTS WITH ISACHEMIC HEART DISEASE AND MALIGNANT DISEASE
title_sort differences in the levels of lipid status in patients with isachemic heart disease and malignant disease
topic lipid status
cardiovascular disease
risk factors
malignant disease
url http://publisher.medfak.ni.ac.rs/2009-html/1-broj/DIFFERENCES%20IN%20THE%20LEVELS....pdf
work_keys_str_mv AT beretkaatila differencesinthelevelsoflipidstatusinpatientswithisachemicheartdiseaseandmalignantdisease
AT branislavabrkic differencesinthelevelsoflipidstatusinpatientswithisachemicheartdiseaseandmalignantdisease
AT miodragdjordjevic differencesinthelevelsoflipidstatusinpatientswithisachemicheartdiseaseandmalignantdisease
AT draganzecevic differencesinthelevelsoflipidstatusinpatientswithisachemicheartdiseaseandmalignantdisease